128 related articles for article (PubMed ID: 38173196)
1. Integrating Single-cell and Bulk RNA-seq to Construct a Metastasis-related Model for Evaluating Immunotherapy and Chemotherapy in Uveal Melanoma.
Du Y; Jiang X; Zhang Y; Ying J; Yi Q
Curr Med Chem; 2024 Jan; ():. PubMed ID: 38173196
[TBL] [Abstract][Full Text] [Related]
2. Construction and verification of a hypoxia-related nine-gene prognostic model in uveal melanoma based on integrated single-cell and bulk RNA sequencing analyses.
Zhang X; Qiu J; Huang F; Han P; Shan K; Zhang C
Exp Eye Res; 2022 Oct; 223():109214. PubMed ID: 35981602
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
[TBL] [Abstract][Full Text] [Related]
4. Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy.
Qin Y; Bollin K; de Macedo MP; Carapeto F; Kim KB; Roszik J; Wani KM; Reuben A; Reddy ST; Williams MD; Tetzlaff MT; Wang WL; Gombos DS; Esmaeli B; Lazar AJ; Hwu P; Patel SP
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33203661
[TBL] [Abstract][Full Text] [Related]
5. Role of gene signature regulation in tumor immune microenvironment on the mechanism of uveal melanoma metastasis.
Shi K; Tang J; Yuan L; Zhou S; Ran W; Wang Z
Cancer Biomark; 2023; 36(2):161-175. PubMed ID: 36683494
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of tumor microenvironment-related lncRNA prognostic signature for uveal melanoma.
Liao CL; Hu N; Sun XY; Zhou Q; Tian M; Cao Y; Lyu HB
Int J Ophthalmol; 2021; 14(8):1151-1159. PubMed ID: 34414077
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma.
Hu Y; Cai J; Ye M; Mou Q; Zhao B; Sun Q; Lou X; Zhang H; Zhao Y
Front Immunol; 2022; 13():1037128. PubMed ID: 36466923
[TBL] [Abstract][Full Text] [Related]
8. The immune cell landscape of metastatic uveal melanoma correlates with overall survival.
Tosi A; Cappellesso R; Dei Tos AP; Rossi V; Aliberti C; Pigozzo J; Fabozzi A; Sbaraglia M; Blandamura S; Del Bianco P; Chiarion-Sileni V; Rosato A
J Exp Clin Cancer Res; 2021 May; 40(1):154. PubMed ID: 33947438
[TBL] [Abstract][Full Text] [Related]
9. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
Liu J; Lu J; Li W
Front Immunol; 2021; 12():738068. PubMed ID: 34630418
[TBL] [Abstract][Full Text] [Related]
10. Construction and validation of a novel prognostic signature for uveal melanoma based on five metabolism-related genes.
Zhao H; Chen Y; Shen P; Gong L
Math Biosci Eng; 2021 Sep; 18(6):8045-8063. PubMed ID: 34814288
[TBL] [Abstract][Full Text] [Related]
11. Identification of survival-related genes and a novel gene-based prognostic signature involving the tumor microenvironment of uveal melanoma.
Lei S; Zhang Y
Int Immunopharmacol; 2021 Jul; 96():107816. PubMed ID: 34162166
[TBL] [Abstract][Full Text] [Related]
12. Construction and Validation of a Novel Immunosignature for Overall Survival in Uveal Melanoma.
Gu C; Gu X; Wang Y; Yao Z; Zhou C
Front Cell Dev Biol; 2021; 9():710558. PubMed ID: 34552928
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma.
Ma X; Yu S; Zhao B; Bai W; Cui Y; Ni J; Lyu Q; Zhao J
Front Immunol; 2022; 13():922315. PubMed ID: 35774794
[TBL] [Abstract][Full Text] [Related]
14. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
[TBL] [Abstract][Full Text] [Related]
15. Construction of a Promising Tumor-Infiltrating CD8+ T Cells Gene Signature to Improve Prediction of the Prognosis and Immune Response of Uveal Melanoma.
Sun Y; Wu J; Yuan Y; Lu Y; Luo M; Lin L; Ma S
Front Cell Dev Biol; 2021; 9():673838. PubMed ID: 34124058
[TBL] [Abstract][Full Text] [Related]
16. BAP1 Loss Promotes Suppressive Tumor Immune Microenvironment via Upregulation of PROS1 in Class 2 Uveal Melanomas.
Kaler CJ; Dollar JJ; Cruz AM; Kuznetsoff JN; Sanchez MI; Decatur CL; Licht JD; Smalley KSM; Correa ZM; Kurtenbach S; Harbour JW
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954340
[TBL] [Abstract][Full Text] [Related]
17. Monoacylglycerol lipase regulates macrophage polarization and cancer progression in uveal melanoma and pan-cancer.
Tan Y; Pan J; Deng Z; Chen T; Xia J; Liu Z; Zou C; Qin B
Front Immunol; 2023; 14():1161960. PubMed ID: 37033945
[TBL] [Abstract][Full Text] [Related]
18. Integration of Bulk RNA Sequencing and Single-Cell RNA Sequencing to Reveal Uveal Melanoma Tumor Heterogeneity and Cells Related to Survival.
Gao G; Deng A; Liang S; Liu S; Fu X; Zhao X; Yu Z
Front Immunol; 2022; 13():898925. PubMed ID: 35865532
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition.
Heppt MV; Heinzerling L; Kähler KC; Forschner A; Kirchberger MC; Loquai C; Meissner M; Meier F; Terheyden P; Schell B; Herbst R; Göppner D; Kiecker F; Rafei-Shamsabadi D; Haferkamp S; Huber MA; Utikal J; Ziemer M; Bumeder I; Pfeiffer C; Schäd SG; Schmid-Tannwald C; Tietze JK; Eigentler TK; Berking C
Eur J Cancer; 2017 Sep; 82():56-65. PubMed ID: 28648699
[TBL] [Abstract][Full Text] [Related]
20. Tumor subtypes and signature model construction based on chromatin regulators for better prediction of prognosis in uveal melanoma.
Li Y; Xiong C; Wu LL; Zhang BY; Wu S; Chen YF; Xu QH; Liao HF
Pathol Oncol Res; 2023; 29():1610980. PubMed ID: 37362244
[No Abstract] [Full Text] [Related]
[Next] [New Search]
